A new study shows that 3 cycles of CEV chemotherapy provide noninferior 5-year disease-free survival compared to 6 cycles in ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...

Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...

She was halfway through a regimen last year when one of the two drugs she was taking, carboplatin, became scarce. She said ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Among the current drugs in shortage is carboplatin, a chemotherapy agent used to treat triple negative breast cancer, as well as ovarian and head and neck cancers. Another drug that’s in short ...

Th e GINECO trial explored the combination of trastuzumab with paclitaxel and carboplatin in patients with resistant AOC (< 6 months) and HER2 gene amplification. Patients and Methods: A total of ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to ...

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic ...

Module 2 Selected Case Studies: NUC-3373 plus docetaxel in patients with lung cancer: 60-year-old patient with pleural mesothelioma who had previously received carboplatin plus pemetrexed, the PD-1 ...